Correlation Between Celyad SA and Biocartis Group

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Celyad SA and Biocartis Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Celyad SA and Biocartis Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Celyad SA and Biocartis Group NV, you can compare the effects of market volatilities on Celyad SA and Biocartis Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Celyad SA with a short position of Biocartis Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of Celyad SA and Biocartis Group.

Diversification Opportunities for Celyad SA and Biocartis Group

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Celyad and Biocartis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Celyad SA and Biocartis Group NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biocartis Group NV and Celyad SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Celyad SA are associated (or correlated) with Biocartis Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biocartis Group NV has no effect on the direction of Celyad SA i.e., Celyad SA and Biocartis Group go up and down completely randomly.

Pair Corralation between Celyad SA and Biocartis Group

Assuming the 90 days trading horizon Celyad SA is expected to generate 4.07 times more return on investment than Biocartis Group. However, Celyad SA is 4.07 times more volatile than Biocartis Group NV. It trades about 0.03 of its potential returns per unit of risk. Biocartis Group NV is currently generating about -0.06 per unit of risk. If you would invest  104.00  in Celyad SA on August 30, 2024 and sell it today you would lose (37.00) from holding Celyad SA or give up 35.58% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

Celyad SA  vs.  Biocartis Group NV

 Performance 
       Timeline  
Celyad SA 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Celyad SA are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Celyad SA reported solid returns over the last few months and may actually be approaching a breakup point.
Biocartis Group NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biocartis Group NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental drivers, Biocartis Group is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Celyad SA and Biocartis Group Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Celyad SA and Biocartis Group

The main advantage of trading using opposite Celyad SA and Biocartis Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Celyad SA position performs unexpectedly, Biocartis Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocartis Group will offset losses from the drop in Biocartis Group's long position.
The idea behind Celyad SA and Biocartis Group NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Share Portfolio
Track or share privately all of your investments from the convenience of any device